New Orleans, LA2 Active Studies

Multiple Sclerosis Clinical Trials in New Orleans, LA

Find 2 actively recruiting multiple sclerosis clinical trials in New Orleans, LA. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
156
Enrolling

Recruiting Multiple Sclerosis Studies in New Orleans

About Multiple Sclerosis Clinical Trials in New Orleans

Multiple sclerosis (MS) is an autoimmune disease where the immune system attacks the protective covering of nerve fibers, causing communication problems between the brain and body. Symptoms vary widely and can include vision problems, fatigue, and mobility issues. Disease-modifying therapies have significantly improved outcomes.

There are currently 2 multiple sclerosis clinical trials recruiting participants in New Orleans, LA. These studies are seeking a combined 156 participants. Research is being sponsored by Juno Therapeutics, Inc., a Bristol-Myers Squibb Company, VA Office of Research and Development. Clinical trial participation is free and participants receive study-related medical care at no cost.

Multiple Sclerosis Clinical Trials in New Orleans — FAQ

Are there multiple sclerosis clinical trials in New Orleans?

Yes, there are 2 multiple sclerosis clinical trials currently recruiting in New Orleans, LA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in New Orleans?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New Orleans research site will contact you about next steps.

Are clinical trials in New Orleans free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New Orleans studies also compensate for your time and travel.

What multiple sclerosis treatments are being tested?

The 2 active trials in New Orleans are testing new therapies including novel drugs, biologics, and treatment approaches for multiple sclerosis.

Data updated July 18, 2026 from ClinicalTrials.gov